首页 | 本学科首页   官方微博 | 高级检索  
     

PTEN、MLL基因在T淋巴母细胞淋巴瘤/白血病的表达及其意义
引用本文:郗彦凤,李静,王晋芬,白文启,程林仙. PTEN、MLL基因在T淋巴母细胞淋巴瘤/白血病的表达及其意义[J]. 白血病.淋巴瘤, 2011, 20(4): 202-205
作者姓名:郗彦凤  李静  王晋芬  白文启  程林仙
作者单位:山西省肿瘤医院病理科,太原,030013
摘    要: 目的 分析肿瘤抑制基因PTEN、混合系白血病(MLL)基因等在T淋巴母细胞淋巴瘤/白血病(T-LBL/ALL)的表达及意义。方法 选用76例T-LBL/ALL患者淋巴结存档蜡块,应用免疫组织化学EnVision法进行PTEN标记,用20例反应性增生淋巴结标本作正常对照。并用荧光原位杂交(FISH)技术检测MLL基因所在11q23染色体的断裂和扩增情况。结果 76例T-LBL/ALL中,PTEN的表达率为64.47 %(49/76),低于淋巴结反应性增生的100 %(20/20)(χ2=19.220,P<0.05)。PTEN表达与临床分期、Ki-67、乳酸脱氢酶(LDH)呈负相关(P<0.05)。76例T-LBL/ALL中,MLL基因发生11q23染色体断裂13例(17.11 %),扩增18例(23.68 %)。MLL基因断裂组总体生存率(25.0 %)低于非断裂组(43.6 %)(χ2=11.357,P<0.05)。MLL基因扩增组总体生存率(17.1 %)低于非扩增组(42.7 %)(χ2=4.533,P<0.05)。结论 抑癌基因PTEN表达降低在T-LBL/ALL的发生发展中可能具有重要作用。MLL基因发生染色体11q23断裂和扩增有助于对T-LBL/ALL预后的判断,发生MLL基因断裂或扩增的T-LBL/ALL预后较差,提示MLL基因断裂或扩增可能为T-LBL/ALL的一种分子亚型。

关 键 词:淋巴瘤/白血病,淋巴母细胞  PTEN,基因,肿瘤抑制  基因,MLL

Significance and expression of PTEN, MLL gene in T lymphoblastic lymphoma/leukemia
XI Yan-feng,LI Jing,WANG Jin-fen,BAI Wen-qi,CHENG Lin-xian. Significance and expression of PTEN, MLL gene in T lymphoblastic lymphoma/leukemia[J]. Journal of Leukemia & Lymphoma, 2011, 20(4): 202-205
Authors:XI Yan-feng  LI Jing  WANG Jin-fen  BAI Wen-qi  CHENG Lin-xian
Affiliation:. Department of Pathology, Shanxi Cancer Hospital, Taiyuan 030013, China
Abstract:Objective To investigate the significance and expression of PTEN, MLL in T lymphoblastie lymphoma/leukaemia(T-LBL/ALL). Methods Seventy-six cases of T-LBL/ALL were studied by using immunohistochemical EnVision method for PTEN. Fluorescence in-situ hybridization (FISH) for MLL gene (located on chromosome 1 lq23) was performed to detect its breakage and amplification. Results Among the 76 cases of T- LBL/ALL, the positive rate of PTEN was 64.47 % (49/76), lower than that in reactivated lymphoid tissue (100 %, 20/20) (X^2= 19.220, P 〈0.05). PTEN expression was reversely correlated to the clinical stage, Ki-67 index and LDH level (P 〈0.05). Among the 76 cases, MLL gene with breakage of 11q23 was detected in 13 cases (17.11%), and amplification in 18 cases (23.68 %). Survival rate of MLL gene breakage group was lower than that of non-breakage group (25.0 %, 43.6 %). Survival rate of MLL gene amplification group was lower than that of non-amplification group too (17.1%, 42.7 %). Both of breakage and amplification were related to prognosis ( X 2 = 11.357, X^2=4.533; P 〈0.05). Conclusion Anti-oncogene PTEN down-regulation may play an important role on the development and proceeding of T-LBL/ALL. MLL gene with breakage and amplification of 11q23 are helpful to predict prognosis of T-LBL/ALL. The case with MLL gene breakage and amplification of T-LBL/ALL may have a poor prognosis. It hints this group maybe a subtype of T-LBIdALL.
Keywords:Lymphoma/leukaemia, lymphoblastie  PTEN, gene, tumor suppressor  Gene, MLL
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《白血病.淋巴瘤》浏览原始摘要信息
点击此处可从《白血病.淋巴瘤》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号